FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.060
-0.090 (-7.83%)
At close: Aug 14, 2026, 4:00 PM EDT
1.100
+0.040 (3.77%)
After-hours: Aug 14, 2026, 7:34 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $7.06 million as of August 14, 2026. Its market cap has decreased by -71.40% in one year.
Market Cap
7.06M
Enterprise Value
5.00M
1-Year Change
-71.40%
Ranking
Category
Stock Price
$1.06
ChartMarket Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $7.06M, a decrease of -99.25%. That is a compound annual growth rate of -85.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 7.06M | -52.82% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AIM ImmunoTech | 7.82M |
| Niki BioSolutions | 7.80M |
| Xenetic Biosciences | 7.73M |
| Kairos Pharma | 7.59M |
| MetaVia | 7.59M |
| Can-Fite BioPharma | 7.41M |
| CNS Pharmaceuticals | 7.32M |
| AEON Biopharma | 7.23M |